As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on ...

European healthcare stocks fell sharply on Wednesday as investors braced for potential tariffs on the pharmaceutical industry ...

India's benchmark indexes opened lower on Thursday after U.S. President Donald Trump slapped 26% reciprocal tariffs on ...

Investors in pharma and auto stocks are anxious ahead of the April 2 deadline for US tariffs. Despite a 6% fall over three sessions, experts believe the panic is unfounded, maintaining confidence in ...

US President Donald Trump’s 26% reciprocal tariff on India is expected to have the greatest impact on the automotive, IT, and ...

The exemption given to Indian pharmaceuticals is positive and, therefore, this segment is likely to witness buying, says ...

Moderna (MRNA) is another interesting choice today. MRNA stock has dropped 11.66% alongside the FDA news, the largest of the ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $502.55, marking a +0.45% move from the previous day. The stock's change was more than the S&P 500's daily loss of 0.33%.

There’s noticeable anxiety among investors in the pharma and auto sectors ahead of the April 2 deadline, when US President Donald Trump’s tariffs are set to take effect. This has been reflected in the ...

The delisting action was determined after Virpax Pharmaceuticals failed to regain compliance with Nasdaq Listing Rule 5550 (b) (1). The delisting process will conclude with the filing of a Form 25 ...

President Trump's new tariffs send shockwaves through U.S. markets as a trade war unfolds. Follow along for live updates on ...